The critical role of ACTN1 in modulating chemosensitivity in HNSCC suggests its potential as a robust predictive biomarker for chemotherapy responses and as a candidate for therapeutic intervention to overcome drug resistance. The gene discussed is ACTN1; the disease is head and neck squamous cell carcinoma.